1.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-02530, 10-182-B, UCCRC-10-182-B, CDR0000685236, N01CM00071, 8317, NCT01208051
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00198, MC057H, CDR0000588044, N01CM00099, MAYO-MC057H, 7627, NCT00625846
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2013-00554, OSU 12154, N01CM00070, NCT01811212
|
|
4.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-087, NCT01412762
|